AKT1 and neurodegenerative disease: These results indicate that AKT inhibition reduces the neuronal toxicity caused by reactive astrocytes, and therefore, aiming to this network represents a promising therapeutic target to control astrocyte reactivity and the progression of neurodegenerative diseases.